serena williams tirzepatide is returning to tennis — and bringing the GLP-1 debate with her Serena Williams explains why she

What are the limitations of liposomal drug delivery

Peak intensity is usually reached between days two and four

You can always contact us for more information about the sources of our data about you

So the question is this: are we going to keep chasing unrealistic numbers, or are we ready to build care models that actually deliver them

The role of short-chain fatty acids from gut microbiota in gut-brain communication

Clinical Effectiveness: SURMOUNT-1 Trial (Tirzepatide 15 mg): Duration: 72 weeks Participants: 2,539 adults with obesity Average Weight Loss: 22.5% of body weight 10 mg Dose: 21.4% weight loss 5 mg Dose: 15.0% weight loss Placebo: 2.4% weight loss 5% Weight Loss: 96% of participants 10% Weight Loss: 89% of participants 15% Weight Loss: 78% of participants 20% Weight Loss: 63% of participants This is the best weight loss result ever achieved with medication in clinical trials